OTC · HLTHQ
Cue Health Inc.
$0.00$0.00 (0.0%)
Cue Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · CLVR · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Clever Leaves Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Clever Leaves Holdings Inc.’s next earnings report is currently expected on Nov 13, 2026, with estimated earnings per share of -$10.95. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Clever Leaves Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Clever Leaves Holdings Inc. is a company primarily focused on the cannabis sector. Its operations are structured into two distinct divisions: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment oversees the global cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid-based products. In contrast, the Non-Cannabinoid segment, operating within the United States, specializes in the formulation, production, marketing, sales, and delivery of a diverse array of nutraceuticals, natural remedies, wellness items, detoxification solutions, and various nutritional and dietary supplements. These products are supplied to a broad clientele, including mass retailers, specialized health stores, and distributors. The company was founded in 2017 and is headquartered in Boca Raton, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:39 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2022 | Nov 9, 2022 | -$0.48+90.77% vs estimate | $3.31M-39.93% vs estimate |
|---|
| Q2 2022 | Aug 11, 2022 | -$6.01+12.9% vs estimate | $4.66M-16.06% vs estimate |
|---|
| Q1 2022 | May 12, 2022 | -$15.62-18.33% vs estimate | $5.22M+19.19% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Cue Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Biocept, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.0% below the high.
$0.00$0.00 (0.0%)
Brain Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Verde Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Biostar Pharmaceuticals, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
HTG Molecular Diagnostics, Inc.: Healthcare · Medical - Diagnostics & Research.
